BACKGROUND Hirsutism, defined by the presence of excessive terminal hair in androgen-
sensitive areas of the female body, is one of the most common disorders in women during …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women
of reproductive age and is associated with various metabolic perturbations, in addition to …

Preeclampsia (PE) is a multisystem disorder that typically affects 2%− 5% of pregnant
women and is one of the leading causes of maternal and perinatal morbidity and mortality …

Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …

Abstract Objective To update the “Evaluation and Treatment of Hirsutism in Premenopausal
Women: An Endocrine Society Clinical Practice Guideline,” published by the Endocrine …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with
a high prevalence. The etiology of this heterogeneous condition remains obscure, and its …

Since the 1990 National Institutes of Health–sponsored conference on polycystic ovary
syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader …

Background Polycystic ovary syndrome (PCOS) is characterised by infrequent or absent
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …

BACKGROUND Our aim was to assess differences in anxiety and depression between
women with and without (controls) polycystic ovary syndrome (PCOS). METHODS We …

Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …